NCT07365384Not yet recruiting
Pelvic-Restricted vs. Pelvic-Free Robot-Assisted Gait Training in Stroke Patients
Comparison of Pelvic-Free and Pelvic-Restricted Robot-Assisted Gait Training on Walking Pattern, Balance, and Fear of Falling After Stroke
Source: ClinicalTrials.gov · Last updated 26 Jan 2026
Brief summary (registry, in English)
This randomized controlled clinical trial aims to compare the effects of pelvic-free versus pelvic-restricted robot-assisted gait training (RAGT) on gait pattern, balance, and fear of falling in stroke patients. Stroke survivors often experience gait impairments, reduced balance, and fear of falling, which limit independence and quality of life. Conventional physiotherapy requires high intensity and repetition but is restricted by therapist capacity. Robotic gait systems provide intensive, repetitive, and safe training; however, most limit pelvic motion, potentially disrupting natural gait patterns and balance strategies. A total of 36 participants with chronic stroke (≥6 months post-stroke, age ≥18 years, hemiplegic gait disorder, Functional Ambulation Category ≥2) will be randomized into two groups: (1) pelvic-free RAGT plus conventional rehabilitation, or (2) pelvic-restricted RAGT plus conventional rehabilitation. Interventions will consist of 8 RAGT sessions (twice weekly) and 20 conventional rehabilitation sessions (five times weekly) over 4 weeks. Primary outcomes include gait analysis parameters (gait speed, step length, cadence, temporal symmetry index) and clinical measures such as the Berg Balance Scale, Functional Ambulation Category, Motricity Index (lower limb), and Falls Efficacy Scale-International. Assessments will be performed at baseline and after 4 weeks of treatment. The study hypothesizes that pelvic-free RAGT will improve gait symmetry, balance, and reduce fear of falling more effectively than pelvic-restricted training. Results are expected to provide evidence supporting the integration of pelvic-free robotic gait systems into post-stroke rehabilitation to enhance functional recovery and patient confidence
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 26 Sept 2025
- Start date
- 15 Jan 2026
- Primary completion date
- Apr 2026
- Lead sponsor
- Meltem Gunes Akinci
- Diseases
- Stroke
- NCT number
- NCT07365384
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 15 Jan 2026 to the primary completion date, Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive or communication impairment
- Uncontrolled hypertension or orthostatic hypotension
- Severe cardiovascular disease, heart failure, cancer, or serious pulmonary disease
- Gait impairment caused by lower extremity musculoskeletal disorders
Other
- Movement limitations due to joint contracture or deformity
- Presence of open wounds or pressure ulcers
- High risk of fracture due to severe osteoporosis
- Severe psychosis/neurosis
- Modified Ashworth Scale \> 3 in the lower extremities (severe spasticity)
Who the study is looking for
- Age 18 years or older
- History of stroke more than 6 months prior
- Presence of hemiplegia-related gait disorder
- Functional Ambulation Category (FAC) score ≥ 2
- Ability to walk independently prior to stroke
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.